Discover 604 paid clinical trials in Norman, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 604
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Oklahoma City OK, Flower Mound TX, Little Rock AR,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & ResponsiveNew
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
for
Influenza
Location: Oklahoma City OK, Yukon OK, Edmond OK, Tulsa OK,
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Norman OK, Southlake TX, Wichita KS, Arlington TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: Norman OK, Southlake TX, Garland TX, Dallas TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06589986
Phase3, Recruiting
Active & Responsive
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
for
Colonic Neoplasms, Neoplasms, Colon
Location: Oklahoma City OK, Dallas TX, Joplin MO, Westwood KS,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05855200
Phase3, Recruiting
Active & Responsive
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
for
Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma
Location: Oklahoma City OK, Houston TX, Webster TX, Nashville TN,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05431270
Phase1, Phase2, Recruiting
Active & Responsive
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: Oklahoma City OK, Irving TX, Houston TX, San Antonio TX,